Background and Strategy
During the past year there has been increasingly widespread recognition of the human and financial costs of the HIV/AIDS pandemic and a new commitment from national governments and donor countries to address this issue. This commitment is apparent in the establishment and initiation of the Global Fund to Fight AIDS, Tuberculosis and Malaria, in the report of the WHO Commission on Macroeconomics and Health, and in new USAID initiatives. While donors and governments alike stand prepared to support expansion of HIV services, particularly the delivery of antiretroviral drugs (ARV), there are still substantial gaps in our knowledge about the system requirements for operating a successful ARV program, how to plan for such a program, the cost implications of ARV and other treatment/care strategies, and how to finance these costs in the longer term.
The work that PHRplus is undertaking on HIV/AIDS is designed to answer some of these questions. A variety of approaches are being used, including evaluation and analysis of existing programs, and the development of tools to help decision makers.
- Piloting a tool to help policymakers design cost-effective ARV programs
- Assessing the costs of home-based care
- Financing HIV/AIDS care
- Providing technical support for developing national HIV/AIDS strategies and proposals
- National Health Accounts and HIV/AIDS
- Publication of a high profile primer